These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6388382)

  • 21. [Treatment of breast cancer with ipsilateral supraclavicular node metastases].
    Ning L; Yu J; Lin C
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):139-41. PubMed ID: 7656807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.
    Jacobson JA; Danforth DN; Cowan KH; d'Angelo T; Steinberg SM; Pierce L; Lippman ME; Lichter AS; Glatstein E; Okunieff P
    N Engl J Med; 1995 Apr; 332(14):907-11. PubMed ID: 7877647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
    Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
    Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy for breast cancer.
    Dent DM
    S Afr Med J; 1977 Oct; 52(18):714-6. PubMed ID: 601641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Necessity of adjuvant therapy after radical mastectomy based on a study of patients with negative nodes, who have recurrent breast cancer].
    Asagoe T; Yamoto H; Nemoto A; Shikata J; Aoki A; Nakayama R; Tashiro Y
    Gan No Rinsho; 1988 Jan; 34(1):41-4. PubMed ID: 3339848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.
    Veronesi U; Saccozzi R; Del Vecchio M; Banfi A; Clemente C; De Lena M; Gallus G; Greco M; Luini A; Marubini E; Muscolino G; Rilke F; Salvadori B; Zecchini A; Zucali R
    N Engl J Med; 1981 Jul; 305(1):6-11. PubMed ID: 7015141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.
    Ragaz J; Jackson SM; Le N; Plenderleith IH; Spinelli JJ; Basco VE; Wilson KS; Knowling MA; Coppin CM; Paradis M; Coldman AJ; Olivotto IA
    N Engl J Med; 1997 Oct; 337(14):956-62. PubMed ID: 9309100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of operable breast cancer: the surgeon's view.
    Urban JA
    Cancer; 1978 Oct; 42(4):2066-77. PubMed ID: 101302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.
    Ludwig Breast Cancer Study Group
    N Engl J Med; 1989 Feb; 320(8):491-6. PubMed ID: 2644533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
    Poortmans PM; Collette S; Kirkove C; Van Limbergen E; Budach V; Struikmans H; Collette L; Fourquet A; Maingon P; Valli M; De Winter K; Marnitz S; Barillot I; Scandolaro L; Vonk E; Rodenhuis C; Marsiglia H; Weidner N; van Tienhoven G; Glanzmann C; Kuten A; Arriagada R; Bartelink H; Van den Bogaert W;
    N Engl J Med; 2015 Jul; 373(4):317-27. PubMed ID: 26200978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
    Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.
    Barlow WE; Taplin SH; Yoshida CK; Buist DS; Seger D; Brown M
    J Natl Cancer Inst; 2001 Mar; 93(6):447-55. PubMed ID: 11259470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant radiation after modified radical mastectomy for breast cancer fails to prolong survival.
    Geisler DP; Boyle MJ; Malnar KF; Melichar RM; McGee JM; Nolen MG; Broughan TA
    Am Surg; 2000 May; 66(5):452-8; discussion 458-9. PubMed ID: 10824745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.